Primary |
|
Dermatitis Herpetiformis |
50.0% |
No Adverse Event |
50.0% |
|
Secondary |
Diabetes Mellitus |
18.8% |
Product Used For Unknown Indication |
12.5% |
Rheumatoid Arthritis |
9.4% |
Anxiety |
6.3% |
Insomnia |
6.3% |
Prophylaxis |
6.3% |
Angina Pectoris |
3.1% |
Blood Cholesterol |
3.1% |
Breast Cancer |
3.1% |
Constipation |
3.1% |
Gastrooesophageal Reflux Disease |
3.1% |
Hypertension |
3.1% |
Hypoaesthesia |
3.1% |
Hypothyroidism |
3.1% |
Metastases To Bone |
3.1% |
Multiple Sclerosis |
3.1% |
Osteoporosis |
3.1% |
Pain |
3.1% |
Thyroid Disorder |
3.1% |
|
Tremor |
22.2% |
Completed Suicide |
11.1% |
Death |
11.1% |
Drug Hypersensitivity |
11.1% |
Heart Rate Decreased |
11.1% |
Myalgia |
11.1% |
Peripheral Sensory Neuropathy |
11.1% |
Rheumatoid Arthritis |
11.1% |
|
Concomitant |
Product Used For Unknown Indication |
30.4% |
Osteoporosis |
9.8% |
Hypothyroidism |
7.9% |
Asthma |
7.0% |
Hormone Replacement Therapy |
4.5% |
Thyroid Disorder |
4.4% |
Hypertension |
4.1% |
Depression |
4.0% |
Osteopenia |
4.0% |
Rheumatoid Arthritis |
3.5% |
Hypersensitivity |
3.2% |
Anxiety |
2.6% |
Pain |
2.5% |
Seasonal Allergy |
2.3% |
Atrial Fibrillation |
2.1% |
Blood Pressure |
1.8% |
Blood Cholesterol Increased |
1.7% |
Chronic Obstructive Pulmonary Disease |
1.6% |
Fibromyalgia |
1.6% |
Factor Iii Deficiency |
1.5% |
|
Weight Decreased |
12.1% |
Nausea |
7.3% |
Pain |
7.3% |
Wound Infection Staphylococcal |
6.7% |
Wheezing |
6.1% |
Malaise |
5.5% |
Pain In Extremity |
5.5% |
Vomiting |
5.5% |
Drug Ineffective |
4.8% |
Vision Blurred |
4.8% |
Weight Increased |
4.8% |
Swelling Face |
4.2% |
Insomnia |
3.6% |
Rash |
3.6% |
Urticaria |
3.6% |
Breast Cancer Female |
3.0% |
Flushing |
3.0% |
Myalgia |
3.0% |
Product Quality Issue |
3.0% |
Depression |
2.4% |
|